Decompensated Heart Failure Can Occur Without NT‑proBNP Elevation

Clinical Scenarios in Which NT‑proBNP May Be Low

Patients with decompensated heart failure may have normal or only modestly elevated NT‑proBNP levels, particularly in flash pulmonary edema, end‑stage disease, isolated right‑sided failure, obesity, or very early presentation. 1, 2
Flash pulmonary edema: at the moment of presentation NT‑proBNP can be normal or only slightly raised because insufficient time has elapsed for ventricular synthesis and release of natriuretic peptides. Levels typically increase markedly within the next few hours despite appropriate therapy. 3
End‑stage decompensated heart failure: severely ill patients may show unexpectedly low NT‑proBNP despite marked clinical decompensation, reflecting an exhausted ventricular synthetic capacity. 1
Isolated right‑ventricular failure generates less natriuretic peptide release than left‑sided failure, resulting in lower NT‑proBNP elevations. 1
Obesity (BMI ≥ 30 kg/m²): for any given degree of cardiac dysfunction, obese individuals consistently exhibit lower BNP and NT‑proBNP concentrations. In acute decompensation, BNP values as low as 60–100 pg/mL have been reported. 4, 5, 3

Heart‑failure diagnosis remains primarily clinical: it requires either two physical‑examination findings or one physical finding plus one laboratory/radiological criterion (e.g., imaging evidence of congestion); NT‑proBNP alone is insufficient. 4, 5
Key physical‑examination signs include peripheral edema, pulmonary crackles/rales, elevated jugular venous pressure, an S3 gallop, rapid weight gain > 3–4 lb over 3–4 days, or new abdominal distention/ascites. 4, 5
Alternative laboratory evidence
- Radiological signs of pulmonary congestion on chest X‑ray, CT, or MRI (e.g., interstitial edema, pleural effusion, cephalization). 4, 5
- Echocardiographic evidence of elevated filling pressures, reduced left‑ventricular ejection fraction < 50 %, or other structural/functional abnormalities. 4, 5

Routine NT‑proBNP measurement is not recommended in patients with an obvious clinical diagnosis of heart failure; it should not replace bedside assessment or echocardiography. 7, 8
Lower NT‑proBNP values decrease the likelihood of heart failure but do not exclude it, especially in the scenarios above; clinicians must interpret results in context. 1, 4, 5
In patients with chronically elevated natriuretic peptides, no specific absolute or relative rise defines acute decompensation; clinical judgment remains paramount. 4, 5

Repeating NT‑proBNP several hours after initial presentation can uncover the expected rise in flash pulmonary edema or early ischemic presentations, aiding diagnosis when the first value is low. 3